Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 9Squamous Cell Carcinoma of Head and Neck 7Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 5Urinary Bladder Neoplasms 4Mesothelioma, Malignant 4Urethral Neoplasms 3Small Cell Lung Carcinoma 3Oropharyngeal Neoplasms 3Neuroblastoma 3Medulloblastoma 3Ganglioneuroblastoma 3Cholangiocarcinoma 3Vulvar Neoplasms 2Vaginal Neoplasms 2Ureteral Neoplasms 2Tongue Neoplasms 2Prostatic Neoplasms 2Lymphoid Interstitial Pneumonia 2Laryngeal Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Transitional Cell 2Brenner Tumor 2Vomiting 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Solitary Fibrous Tumor, Pleural 1Sertoli-Leydig Cell Tumor 1

Interventions

Gemcitabine 19Cisplatin 11Capecitabine 9Oxaliplatin 7Fluorouracil 5pembrolizumab 4Leucovorin 4Sorafenib 3Magnetic Resonance Spectroscopy 3Erlotinib Hydrochloride 3trifluridine tipiracil drug combination 2regorafenib 2cobimetinib 2atezolizumab 2Trastuzumab 2Taxes 2Specimen Handling 2Platinum 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Lapatinib 2Biopsy 2Bevacizumab 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2zanidatamab 1varlilumab 1vandetanib 1tucatinib 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Gallbladder Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT03768414 2026-01-12

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

SWOG Cancer Research Network

Phase 3 Completed
452 enrolled 17 charts
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02392637 2022-02-02

Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers

M.D. Anderson Cancer Center

Phase 2 Completed
62 enrolled 10 charts
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡